Pay in 4 interest-free payments of $5.90 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
I even wobbled up to the shed today with a bit of support and had a "new" b12 injection yesterday
KLOW is not a weight-loss blend
Current research limitations include the absence of large-scale randomized clinical trials in humans, an still partial understanding of the precise molecular mechanisms, and a lack of detailed pharmacokinetic data in humans
Product Features Mitochondria-derived peptide (MDP) Lyophilised powder for enhanced stability High purity verified through independent third-party analytical testing Suitable for in-vitro and preclinical research applications Tamper-evident, batch-labelled packaging Designed for laboratory and investigative research use only Research Applications MOTS-c is extensively researched in laboratory environments involving: Mitochondrial signalling and communication pathway investigations Metabolic flexibility and energy homeostasis studies Cellular stress resistance and adaptive response modelling Skeletal muscle metabolism and exercise-related pathway analysis Age-related cellular function and metabolic regulation research Peptide-mediated mitochondrial communication systems Its mitochondrial origin has made MOTS-c a valuable compound within controlled metabolic and mitochondrial research models
The absence of adverse events in a 12-week window is encouraging but insufficient to characterise long-term risk
US$ 21.52
US$ 20.78
US$ 25.38
US$ 24.75
US$ 21.15
